SchoolCare uses telepresence robots, school navigation, and teleteaching to keep children with cancer connected to school.
Official title: SchoolCare: A Social Intervention Introducing Telepresence Robots and School Navigation to Reduce School Fragmentation for Children Undergoing Cancer Treatment - Study Protocol of a Multi-Site Randomized Controlled Trial (RCT)
Run by Copenhagen University Hospital, Rigshospitalet · NCT07398677 · Data updated 2026-11-12
This program will test whether telepresence robots combined with school navigation and teleteaching help children aged 5–17 undergoing cancer treatment stay linked to school and improve attendance, learning, and social well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 5 Years to 17 Years |
| Sex | All |
| Enrollment | 128 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 3 sites (Aalborg and 2 other locations) |
| Status | Recruiting |
| Started | February 20, 2026 |
| Main results expected | September 30, 2028 |
| Study ends | September 30, 2028 |
| Registry record updated | March 19, 2026 |
| Trial ID | NCT07398677 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 5–17 treated at the participating Danish pediatric oncology centers who were diagnosed or had relevant disease events within two months and are expected to miss more than one school day per week over an eight-month period are ideal candidates.
✕Probably not a fit
Children who cannot communicate in Danish, who are physically unable to use or engage with telepresence technology, who already maintain regular school attendance, or who obtain a telepresence robot outside the program are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
SchoolCare is a multi-site, two-arm randomized controlled trial conducted at three pediatric oncology centers in Denmark (Copenhagen, Aarhus, Aalborg). Participants are randomly assigned to receive a package that includes a telepresence robot, a dedicated school navigator, teleteaching, and technical support, versus usual care. The trial targets children expected to miss substantial school time during treatment and measures outcomes such as school attendance, academic level, and social well-being over an eight-month period. The intervention aims to combine technology and coordination to reduce fragmented schooling and support psychosocial adjustment during treatment.
Why it matters
Potential benefit: If successful, the program could reduce school absences, support continuous learning, and improve social connectedness for children during cancer treatment.
How similar studies have gone: Telepresence robots have been used to support classroom participation for other medical groups, but no rigorous randomized trials have yet demonstrated benefit specifically for children undergoing cancer treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Children and adolescents are eligible for inclusion if they meet the following criteria: they are: (1) diagnosed with cancer or cancer-like diseases withing two months of inclusion (e.g., benign brain tumors, MDS, or LCH ); (2) have undergone a stem cell transplant, or have experienced cancer relapse or disease progression within the two months of inclusion; (3) aged 5-17 years; (4) admitted to the pediatric oncology ward at Copenhagen University Hospital, Aarhus University Hospital, or Aalborg University Hospital; (5) expected to experience disrupted schooling, defined as absence of more than one school day per week over an anticipated period of eight months; and (6) enrolled, or expected enrolment, in a school in Denmark during the eight month intervention period. Participants will be excluded if: (1) the children in intervention arm B obtain a telepresence robot outside of the SchoolCare intervention; (2) the child is unable to communicate in Danish; or (3) the child has physical or cognitive impairments that prevent them from operating or meaningfully engaging with the telepresence robot. Assessment of the latter criterion will be conducted jointly by hospital personnel and the school navigator to determine whether the child is likely to benefit from participation in the intervention. All reasons for exclusion will be documented and reported in accordance with CONSORT guidelines \[47\] supplemented by the CONSORT-SPI extended version of social and psychological interventions \[48\]. Parents and teachers of the participating children will also be included in the study and invited to complete questionnaires as well as take part in semi-structured interviews. Recruitment began on February 1st, 2026.
Where it's running
-
Aalborg Universitetshospital
Aalborg, Denmark Recruiting -
Aarhus Universitetshospital
Aarhus, Denmark Recruiting -
Rigshospitalet
Copenhagen, Denmark Recruiting
Study contacts
- Study coordinator: Hanne B Larsen
- Email: hanne.baekgaard.larsen@regionh.dk
- Phone: 34459647
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Taabo Tutoring: Can Peer or Teacher Help Teens Stay in School and Do Better?
This study tests whether peer tutoring or teacher tutoring helps at-risk Grade 10 students and previously unenrolled adolescents stay in school and improve academic results in Taabo, Côte d'Ivoire.
-
Mind-body therapies to help anxiety in young cancer survivors
This study tests whether hypnosis and relaxation, added to usual care, can reduce anxiety in children, teens, and young adults who have survived cancer.
-
Pain and sleep problems in children who survived cancer
This study tests how pain and sleep disturbances relate in children who survived cancer compared with healthy peers.
-
Time-restricted eating for adult survivors of childhood cancer
This study will test whether time-restricted eating combined with regular coaching helps adult survivors of childhood cancer lose weight and lower heart and metabolic risk compared with standard education and monthly weigh-ins.
-
Parent-FORT: Fear of Cancer Recurrence therapy for parents of childhood cancer survivors
This pilot tests a virtual group therapy called Parent-FORT to see if it reduces fear of cancer recurrence and improves quality of life for parents of childhood cancer survivors.
-
Evaluating fertility and ovarian function in female childhood cancer survivors
This study is testing how certain cancer treatments affect the fertility and ovarian health of women who survived childhood cancer to see if they can find new ways to predict ovarian problems later on.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.